Innoviva Specialty Therapeutics, Inc.’s Post

https://lnkd.in/gV9ymdGJ Excited to see our consensus guidelines for #infectiousdiseases screening in #hidradenitissuppurativa. Susceptibility to infectious disease varies by condition- so relying upon psoriasis guidelines is sub-optimal. These initial guidelines will hopefully stimulate further evidence development and further guideline refinement.

Please check out this paper from George Anesi et al. Open Forum Infectious Diseases, Volume 10, Issue 8, August 2023, ofad428, https://lnkd.in/grMxnD29

AWG supports legislation and regulatory policies that increase innovation in the treatment of infectious diseases in the US. Learn about the types of incentive reforms that can help address the public health crisis of antimicrobial resistance (AMR).

Antimicrobial resistance is a global threat to public health. In our Expert Insight, Christine M. Cohn, PharmD, BCPS, explains the five ‘Ds’ of antimocrobial stewardship—diagnosis, drug, dose, de-escalation, and duration: https://ow.ly/zs7250PXTXs

Antimicrobial resistance is a global threat to public health. In our Expert Insight, Christine M. Cohn, PharmD, BCPS, explains the five ‘Ds’ of antimocrobial stewardship—diagnosis, drug, dose, de-escalation, and duration: https://ow.ly/zs7250PXTXs

Fortrea is honored to have been able to support Venatorx Pharmaceuticals in this critical antibiotic clinical trial. This article describes the recent randomized trial of Cefepime–taniborbactam on adults with complicated urinary tract infections. Read the new peer-reviewed publication by Patrick McLeroth, M.D., VP and TA Head, and additional authors. Infectious Disease and Critical Care at Fortrea, #clinicaltrials #clinicalresearch

There is only one treatment that pathogens do not develop resistance to: Light. In a few short years, Covid is already adapting to the few treatment options available. While drug companies may be focused on new drugs and longer trials, illumiPure is focused on eliminating the disease before it start in a way that will be safe today, tomorrow, and a decade from now. Whether it's our visible light disinfection solution #CleanWhite or UV-C (#UVC) solution #AirGuardian, our fixtures destroy antimicrobial resistant diseases. #healthybuildings #airquality #covid #covid19 #paxlovid https://lnkd.in/gvh8FFrC

This Thursday, February 29, is Rare Disease Day. It’s observed each year on the last day of February which is the “rarest of calendar dates to underscore the nature of these diseases” and serves to raise awareness of rare diseases and those individuals affected by them. Our latest blog post gives a brief overview of the rare disease landscape and details some recent US regulatory updates. #RareDiseaseDay #FDA #RegulatoryUpdates https://lnkd.in/gbZxa-Jv

Tomorrow is the start of World Antimicrobial Awareness Week, November 18-24. Its theme is “Preventing Antimicrobial Resistance Together”. Here is the last of my posts about AMR – “Resisting Antimicrobial Resistance III – What can we do now to prevent and mitigate AMR?”. It’s available in my free Substack newsletter, “An Ounce of Prevention". #antimicrobialresistance, #amr, #prevention, #publichealth

The Hidden Risk of Linezolid: Navigating Through the Waters of Lactic Acidosis Navigate the hidden risk of linezolid: lactic acidosis. Stay informed for safer treatments. Dive into the details. Learn More: https://lnkd.in/dENQqN5g